Roberto Borea

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Liquid biopsy in oncology practice: A global survey by the Young Committee of the International Society of Liquid Biopsy (ISLB).

Liquid biopsy in oncology practice: A global survey by the Young Committee of the International Society of Liquid Biopsy (ISLB).

Journal: The journal of liquid biopsy

Published: June 19, 2026

Early tumor-informed circulating tumor DNA (ctDNA) dynamics correlate with response to first-line advanced NSCLC treated with pembrolizumab ± chemotherapy.

Early tumor-informed circulating tumor DNA (ctDNA) dynamics correlate with response to first-line advanced NSCLC treated with pembrolizumab ± chemotherapy.

Journal: The journal of liquid biopsy

Published: May 29, 2026

Pulmonary Toxicities of Antibody-Drug Conjugates in Small Cell and Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis.

Pulmonary Toxicities of Antibody-Drug Conjugates in Small Cell and Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: May 18, 2026

Advances in early-stage lung cancer patients: from preanalytics to molecular analysis.

Advances in early-stage lung cancer patients: from preanalytics to molecular analysis.

Journal: Critical reviews in oncology/hematology

Published: March 06, 2026

Cancer in a Drop: Liquid biopsy insights from ESMO 2025.

Cancer in a Drop: Liquid biopsy insights from ESMO 2025.

Journal: The journal of liquid biopsy

Published: February 01, 2026

Corrigendum to "Chemotherapy response monitoring with DNA methylation-based ctDNA tumor fraction: Evidence from a real-world cohort of patients with advanced common solid malignancies" [J Liq Biopsy, 10 (2025), 100442].

Corrigendum to "Chemotherapy response monitoring with DNA methylation-based ctDNA tumor fraction: Evidence from a real-world cohort of patients with advanced common solid malignancies" [J Liq Biopsy, 10 (2025), 100442].

Journal: The journal of liquid biopsy

Published: January 09, 2026

Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies.

Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studies.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 01, 2025

Cancer in a drop: Liquid biopsy highlights from the World Conference on Lung Cancer (WCLC) 2025.

Cancer in a drop: Liquid biopsy highlights from the World Conference on Lung Cancer (WCLC) 2025.

Journal: The journal of liquid biopsy

Published: October 28, 2025

Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022.

Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022.

Journal: Cancer research communications

Published: October 12, 2025

Innovation in next-generation sequencing in non-small cell lung cancer diagnostics.

Innovation in next-generation sequencing in non-small cell lung cancer diagnostics.

Journal: Expert review of anticancer therapy

Published: August 18, 2025

Chemotherapy response monitoring with DNA methylation-based ctDNA tumor fraction: Evidence from a real-world cohort of patients with advanced common solid malignancies.

Chemotherapy response monitoring with DNA methylation-based ctDNA tumor fraction: Evidence from a real-world cohort of patients with advanced common solid malignancies.

Journal: The journal of liquid biopsy

Published: July 24, 2025

Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1, SMARCA4, and PTEN mutations.

Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1, SMARCA4, and PTEN mutations.

Journal: Journal for immunotherapy of cancer

Published: July 04, 2025

Showing 1-12 of 43

Last Updated: 09/26/2026